Sandbox Financial Partners’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.4K | Hold |
24,833
| – | – | ﹤0.01% | 123 |
|
|
2025
Q1 | $16.3K | Hold |
24,833
| – | – | 0.01% | 108 |
|
|
2024
Q4 | $25.3K | Hold |
24,833
| – | – | 0.01% | 107 |
|
|
2024
Q3 | $21.5K | Hold |
24,833
| – | – | 0.01% | 108 |
|
|
2024
Q2 | $8.9K | Hold |
24,833
| – | – | ﹤0.01% | 97 |
|
|
2024
Q1 | $16.6K | Hold |
24,833
| – | – | 0.01% | 97 |
|
|
2023
Q4 | $13.5K | Buy |
+24,833
| New | +$13.5K | 0.01% | 88 |
|
|
2023
Q3 | – | Sell |
-24,833
| Closed | -$32.3K | – | 94 |
|
|
2023
Q2 | $32.3K | Hold |
24,833
| – | – | 0.02% | 93 |
|
|
2023
Q1 | $43.7K | Hold |
24,833
| – | – | 0.03% | 88 |
|
|
2022
Q4 | $78K | Hold |
24,833
| – | – | 0.05% | 86 |
|
|
2022
Q3 | $122K | Hold |
24,833
| – | – | 0.09% | 80 |
|
|
2022
Q2 | $103K | Hold |
24,833
| – | – | 0.07% | 83 |
|
|
2022
Q1 | $144K | Buy |
+24,833
| New | +$144K | 0.08% | 91 |
|